Thimerosal News and Research

RSS
Protein Sciences, UNIGEN agree to supply Flublok influenza vaccine for the U.S. market from Japan

Protein Sciences, UNIGEN agree to supply Flublok influenza vaccine for the U.S. market from Japan

President and CEO of Protein Sciences elected as 2015 Fellow of the International Society for Vaccines

President and CEO of Protein Sciences elected as 2015 Fellow of the International Society for Vaccines

FDA grants exclusivity to Flublok influenza vaccine for 12 years

FDA grants exclusivity to Flublok influenza vaccine for 12 years

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

Protein Sciences, CTH@H to provide Flublok vaccine to home health and hospice agencies in Connecticut

Protein Sciences, [email protected] to provide Flublok vaccine to home health and hospice agencies in Connecticut

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Protein Sciences releases Flublok influenza vaccine for the 2014/2015 season

Protein Sciences releases Flublok influenza vaccine for the 2014/2015 season

FDA approves Protein Sciences' strain change amendment for Flublok influenza vaccine

FDA approves Protein Sciences' strain change amendment for Flublok influenza vaccine

Astellas seeks marketing approval for Flublok recombinant influenza vaccine in Japan

Astellas seeks marketing approval for Flublok recombinant influenza vaccine in Japan

Flublok influenza vaccine for the 2013-14 season now available

Flublok influenza vaccine for the 2013-14 season now available

Unique mobile app allows parents to access information about safety of vaccines

Unique mobile app allows parents to access information about safety of vaccines

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

FDA approves Protein Sciences’ Flublok to prevent seasonal influenza

FDA approves Protein Sciences’ Flublok to prevent seasonal influenza

Experts question proposed mercury preservative ban in vaccines

Experts question proposed mercury preservative ban in vaccines

Banning thimerosal from vaccines could hinder achievements in global childhood immunization

Banning thimerosal from vaccines could hinder achievements in global childhood immunization

Experts warn banning thimerosal from use in vaccines would harm immunization campaigns in developing world

Experts warn banning thimerosal from use in vaccines would harm immunization campaigns in developing world

First Edition: December 17, 2012

First Edition: December 17, 2012

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Sanofi Pasteur files Fluzone sBLA with FDA for treatment of influenza

Sanofi Pasteur files Fluzone sBLA with FDA for treatment of influenza